Given that several groups have reported that the administration of EGF or its homologue HB-EGF can treat experimental NEC [50, 84], it is tempting to speculate that these prior studies may be explained through an inhibitory effect of these growth factors on TLR4 signaling, in addition to their restorative and reparative effects on the intestinal mucosa. This evidence concerns the gene EGF and necrotizing enterocolitis.